Healthcare provider profile · identity verified

Brian Wayne Stigall, MD

Family Practice · NEW BRAUNFELS, TX · NPI 1104834340

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	373	115
Lisinopril	Lisinopril	298	84
Levothyroxine Sodium	Levothyroxine Sodium	273	77
Rosuvastatin Calcium	Rosuvastatin Calcium	208	61
Pantoprazole Sodium	Pantoprazole Sodium	203	57
Amlodipine Besylate	Amlodipine Besylate	201	61
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	200	32
Gabapentin	Gabapentin	188	55
Metformin Hcl	Metformin Hcl	157	47
Clonazepam	Clonazepam	153	20
Escitalopram Oxalate	Escitalopram Oxalate	150	37
Metoprolol Succinate	Metoprolol Succinate	143	40
Tamsulosin Hcl	Tamsulosin Hcl	142	43
Hydrochlorothiazide	Hydrochlorothiazide	141	44
Alprazolam	Alprazolam	128	26
Zolpidem Tartrate	Zolpidem Tartrate	118	20
Omeprazole	Omeprazole	116	34
Losartan Potassium	Losartan Potassium	115	34
Tramadol Hcl	Tramadol Hcl	110	30
Metformin Hcl Er	Metformin Hcl	105	24
Ozempic	Semaglutide	98	16
Valsartan	Valsartan	94	27
Duloxetine Hcl	Duloxetine Hcl	90	23
Allopurinol	Allopurinol	89	22
Donepezil Hcl	Donepezil Hcl	82	22
Fluticasone Propionate	Fluticasone Propionate	81	35
Potassium Chloride	Potassium Chloride	81	22
Glimepiride	Glimepiride	74	20
Pioglitazone Hcl	Pioglitazone Hcl	72	19
Tizanidine Hcl	Tizanidine Hcl	72	22
Simvastatin	Simvastatin	70	18
Albuterol Sulfate Hfa	Albuterol Sulfate	67	32
Sertraline Hcl	Sertraline Hcl	67	20
Meloxicam	Meloxicam	65	25
Furosemide	Furosemide	64	22
Metoprolol Tartrate	Metoprolol Tartrate	62	21
Atenolol	Atenolol	61	16
Montelukast Sodium	Montelukast Sodium	60	20
Pravastatin Sodium	Pravastatin Sodium	58	17
Prednisone	Prednisone	58	39
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	57	17
Celecoxib	Celecoxib	55	18
Diclofenac Sodium	Diclofenac Sodium	54	15
Carvedilol	Carvedilol	53	16
Ezetimibe	Ezetimibe	52	18
Olmesartan Medoxomil	Olmesartan Medoxomil	48	14
Trazodone Hcl	Trazodone Hcl	47	21
Trulicity	Dulaglutide	46	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	45	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	43	suppressed
Famotidine	Famotidine	42	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	39	31
Promethazine Hcl	Promethazine Hcl	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	12
Synthroid	Levothyroxine Sodium	37	12
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	36	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	31
Clonidine Hcl	Clonidine Hcl	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Azelastine Hcl	Azelastine Hcl	33	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	32	suppressed
Alendronate Sodium	Alendronate Sodium	31	11
Benazepril Hcl	Benazepril Hcl	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	31	13
Nebivolol Hcl	Nebivolol Hcl	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Finasteride	Finasteride	28	suppressed
Januvia	Sitagliptin Phosphate	28	suppressed
Jardiance	Empagliflozin	28	12
Pregabalin	Pregabalin	28	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	28	suppressed
Estradiol	Estradiol	27	suppressed
Eszopiclone	Eszopiclone	27	suppressed
Lorazepam	Lorazepam	27	11
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Primidone	Primidone	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Eliquis	Apixaban	24	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Methocarbamol	Methocarbamol	23	suppressed
Testosterone Cypionate	Testosterone Cypionate	23	suppressed
Cephalexin	Cephalexin	22	14
Solifenacin Succinate	Solifenacin Succinate	22	suppressed
Ibuprofen	Ibuprofen	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Citalopram Hbr	Citalopram Hydrobromide	19	suppressed
Diazepam	Diazepam	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Azithromycin	Azithromycin	18	15
Cefdinir	Cefdinir	18	17
Glipizide	Glipizide	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Baclofen	Baclofen	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Methylprednisolone	Methylprednisolone	16	13
Morphine Sulfate Er	Morphine Sulfate	16	suppressed
Novolog Flexpen	Insulin Aspart	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Carisoprodol	Carisoprodol	15	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	15	suppressed
Nystatin	Nystatin	15	suppressed
Phenobarbital	Phenobarbital	15	suppressed
Prolia	Denosumab	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Ketorolac Tromethamine	Ketorolac Tromethamine	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	13	suppressed
Doxepin Hcl	Doxepin Hcl	13	suppressed
Levofloxacin	Levofloxacin	13	13
Modafinil	Modafinil	13	suppressed
Ondansetron Odt	Ondansetron	13	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Risedronate Sodium	Risedronate Sodium	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Dapsone	Dapsone	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Quetiapine Fumarate	Quetiapine Fumarate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error